Arkolith/Insider Trading/AMRX/Form 4

Patel Chirag K.

President & Co-CEO, DirectorAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)93K——1.4M
Mar 4, 2026Tax withholding(F)38K$13.30$503K1.4M
Mar 3, 2026Tax withholding(F)16K$13.31$208K902K
Mar 3, 2026Option exercise(M)60K——918K
Mar 3, 2026Option exercise(M)734K——1.6M
Mar 3, 2026Tax withholding(F)298K$13.31$4.0M1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)93K—$0185K
Mar 3, 2026Option exercise(M)60K—$0180K
Mar 3, 2026Option exercise(M)734K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015283) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML